Home / Health / Govt Caps Cancer Drug Prices: Relief for Patients Soon
Govt Caps Cancer Drug Prices: Relief for Patients Soon
8 Oct
Summary
- Non-scheduled anti-cancer drugs will have a 30% mark-up limit.
- This applies to 110 drugs, including patented and imported ones.
- The move aims to make life-saving cancer medicines affordable.
The government has decided to implement a 30% cap on the mark-ups for all non-scheduled anti-cancer drugs. This directive, announced on October 8, 2026, will apply to the drugs' Maximum Retail Price (MRP) and aims to make cancer treatments more affordable.
The new regulation will encompass approximately 110 different anti-cancer medications. This includes both patented and non-patented formulations, as well as domestically produced and imported medicines. The price reduction is anticipated to bring down costs for many patients.
This strategic move by the government is focused on increasing the accessibility of essential anti-cancer drugs. Officials emphasized that the policy intends to ensure these vital medicines remain available while alleviating the financial strain on patients facing cancer diagnoses.
